Kevin S. Hughes, MD

Co-Director of the Avon Comprehensive Breast Evaluation Center
Surgical Director, Breast Screening Program
Surgical Director, Breast and Ovarian Cancer Genetics and Risk Assessment Program
Massachusetts General Hospital
Boston, MA

Associate Professor of Surgery
Harvard Medical School



Dr. Hughes is a member of the Department of Surgical Oncology at the Massachusetts General Hospital where he is the Surgical Director of the Breast Screening Program, Surgical Director of the Breast and Ovarian Cancer Genetics and Risk Assessment Program, and Co-Director of the Avon Comprehensive Breast Evaluation Center.

He is a graduate of Dartmouth College and Medical School, and trained at Mercy Hospital of Pittsburgh in general surgery. He did a fellowship in surgical oncology at the National Cancer Institute. Dr. Hughes is an Associate Professor of Surgery at Harvard Medical School and was formerly on the faculty of Tufts University, the University of California, and Davis and Brown University. Dr. Hughes has served on numerous national and regional committees and is actively involved in research regarding the genetics, screening, diagnosis and treatment of breast cancer. He is the author of numerous papers and book chapters on the subjects of breast cancer, screening, diagnosis and treatment, and risk assessment.
 

Sherwood S. Hughes

Director of Web Development, Developer and Consultant
Massachusetts General Physicians Organization
Boston, MA








Sherwood Hughes is a member of the Massachusetts General Physicians Organziation at the Massachusetts General hospital  where he develops web based applications and reporting systems. He was educated at Boston University and Harvard University in IT and Economics. Mr. Hughes is also an active community member in Boston's South End and past President of the Blackstone/Franklin Square Neighborhood Association. In collaboration with Dr. Kevin S. Hughes, Christine Lawrence, Brian Drohan, and Phil Bosinoff, Mr. Hughes has created the cancer risk suite of applications available on this site.
 

Brian Drohan 

Brian has previously worked as an embedded systems programmer in the VOIP (Voice Over IP) industry prior to enrolling in a PhD program in the Biomedical Engineering department at the University of Massachusetts.  While completing his course work he has been actively involved in the academic collaboration with the Massachusetts General Hospital in developing methods for the population wide identification of patients at high risk for hereditary breast and ovarian cancer.  His current research interests are in visual analytics, mathematical modeling, and digital image processing.

Phil Bosinoff

Phil Bosinoff is a software consultant specializing in database applications, data mining, and advanced analytics, particularly applications and tools which require some level of mathematical modeling.  He is currently collaborating with others on the Hughes riskApps suite of cancer risk assessment tools.  Mr. Bosinoff has both undergraduate and graduate degrees in electrical engineering and computer science from MIT.  His career spans many years at IBM, ROLM, Tandem, Compaq, and Hewlett-Packard, where he developed several models and products for capacity planning, for computer performance, and for optimizing query execution times.  Mr. Bosinoff has several joint patents for data mining and analytic data analysis tools.  In addition to providing on-going consulting services for HP, Mr. Bosinoff also gets enjoyment tutoring college students in algebra, calculus, and statistics.

 

Chris Lawrence

Chris Lawrence is a software consultant specializing in the development of applications in the biomedical and pharmaceutical industries.  She began her involvement on the Hughes riskApps project in 2005 while she completed her Masters in Biomedical Engineering at the University of Massachusetts Lowell.  Ms. Lawrence obtained a BS in Computer Science from Worcester Polytechnic Institute.  In addition to her work on this project, Ms. Lawrence also works at Pfizer, developing software solutions to support drug discovery.  Her hobbies include sailing, travel and European board games.